{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:28:03Z","timestamp":1783078083447,"version":"3.54.6"},"reference-count":58,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. El uso inadecuado de antibi\u00f3ticos se asocia con aumento de la resistencia antimicrobiana, mayores costos de atenci\u00f3n m\u00e9dica, m\u00e1s efectos adversos y peores resultados cl\u00ednicos.Objetivo. Determinar los patrones de prescripci\u00f3n y las indicaciones aprobadas y no aprobadas para macr\u00f3lidos en un grupo de pacientes en Colombia.Materiales y m\u00e9todos. Se hizo un estudio de corte transversal sobre las indicaciones de uso de macr\u00f3lidos en pacientes ambulatorios a partir de una base de datos de dispensaci\u00f3n de medicamentos de 8,5 millones, aproximadamente, de personas afiliadas al sistema de salud de Colombia. Se consideraron variables sociodemogr\u00e1ficas, farmacol\u00f3gicas y cl\u00ednicas.Resultados. Se encontraron 9.344 pacientes que hab\u00edan recibido prescripci\u00f3n de macr\u00f3lidos; su mediana de edad era de 40,1 a\u00f1os (rango intercuart\u00edlico: 27,1-53,3 a\u00f1os) y el 58,3 % correspond\u00eda a mujeres. El macr\u00f3lido m\u00e1s prescrito fue la azitromicina (38,8 %) y los usos m\u00e1s frecuentes fueron el tratamiento de la infecci\u00f3n por Helicobacter pylori (15,9 %) y la neumon\u00eda (15,8 %). El 31,3 % de las prescripciones correspond\u00eda a indicaciones no aprobadas, destac\u00e1ndose el resfriado com\u00fan (7,8 %), la Covid-19 (4,0 %) y la bronquitis aguda (3,5 %). La residencia en la regi\u00f3n Caribe (OR=1,17; IC95% 1,05-1,31), las prescripciones odontol\u00f3gicas (OR=2,75; IC95% 1,91-3,96), las comorbilidades respiratorias cr\u00f3nicas (OR=1,30; IC95% 1,08-1,56), y la prescripci\u00f3n de eritromicina (OR=3,66; IC95% 3,24-4,14) o azitromicina (OR=2,15; IC95% 1,92-2,41), se asociaron con una mayor probabilidad de recibir macr\u00f3lidos para indicaciones no aprobadas, en tanto que tener entre 18 y 64 a\u00f1os (OR=0,81; IC95% 0,71-0,93), 65 o m\u00e1s a\u00f1os (OR=0,77; IC95% 0,63-0,94) y residir en Bogot\u00e1-Cundinamarca (OR=0,74; IC95% 0,65-0,85) reduc\u00edan dicho riesgo.Conclusiones. La mayor\u00eda de los pacientes recibieron macr\u00f3lidos para infecciones del sistema respiratorio; la eritromicina y la azitromicina se prescribieron en indicaciones no aprobadas en menores de 18 a\u00f1os y en quienes presentaban enfermedades respiratorias cr\u00f3nicas.<\/jats:p>","DOI":"10.7705\/biomedica.6116","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T17:01:11Z","timestamp":1657731671000},"page":"302-314","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":7,"title":["Indicaci\u00f3n y prescripci\u00f3n de macr\u00f3lidos en una poblaci\u00f3n colombiana"],"prefix":"10.7705","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-0101","authenticated-orcid":false,"given":"Luis Fernando","family":"Valladales-Restrepo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2435-2978","authenticated-orcid":false,"given":"Camilo Alexander","family":"Constain-Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-7436","authenticated-orcid":false,"given":"Mar\u00eda Alejandra","family":"Hoyos-Guapacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-4538","authenticated-orcid":false,"given":"Karol Liceth","family":"Hoyos-Guapacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-7658","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Gaviria-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-0986","authenticated-orcid":false,"given":"Manuel Enrique","family":"Machado-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-0936","authenticated-orcid":false,"given":"Jorge Enrique","family":"Machado-Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"109128","doi-asserted-by":"crossref","unstructured":"Chang Y, Chusri S, Sangthong R, McNeil E, Hu J, Du W, et al. Clinical pattern of antibiotic overuse and misuse in primary healthcare hospitals in the southwest of China. PloS ONE. 2019;14:e0214779. https:\/\/doi.org\/10.1371\/journal.pone.0214779","DOI":"10.1371\/journal.pone.0214779"},{"key":"109129","doi-asserted-by":"crossref","unstructured":"Li J, Song X, Yang T, Chen Y, Gong Y, Yin X, et al. A systematic review of antibiotic prescription associated with upper respiratory tract infections in China. Medicine. 2016;95:e3587. https:\/\/doi.org\/10.1097\/MD.0000000000003587","DOI":"10.1097\/MD.0000000000003587"},{"key":"109130","doi-asserted-by":"crossref","unstructured":"Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic resistance: A rundown of a global crisis. Infec Drug Resist. 2018;11:1645-58. https:\/\/doi.org\/10.2147\/IDR.S173867","DOI":"10.2147\/IDR.S173867"},{"key":"109131","doi-asserted-by":"crossref","unstructured":"Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middleincome countries. BMJ Global Health. 2019;4:e002104. http:\/\/dx.doi.org\/10.1136\/bmjgh-2019-002104","DOI":"10.1136\/bmjgh-2019-002104"},{"key":"109132","unstructured":"World Health Organization (WHO). The world health report 2007. A safer future: Global public health security in the 21st century. Geneva: World Health Organization; 2007. Fecha de consulta: 1 de abril de 2021. Disponible en: https:\/\/www.who.int\/whr\/2007\/en\/"},{"key":"109133","doi-asserted-by":"crossref","unstructured":"Sulis G, Adam P, Nafade V, Gore G, Daniels B, Daftary A, et al. Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis. PLoS Medicine. 2020;17:e1003139. https:\/\/doi.org\/10.1371\/journal.pmed.1003139","DOI":"10.1371\/journal.pmed.1003139"},{"key":"109134","doi-asserted-by":"crossref","unstructured":"Butt AA, Navasero CS, Thomas B, Marri SA, Katheeri HA, Thani AA, et al. Antibiotic prescription patterns for upper respiratory tract infections in the outpatient Qatari population in the private sector. Int J Infect Dis. 2017;55:20-3. https:\/\/doi.org\/10.1016\/j.ijid.2016.12.004","DOI":"10.1016\/j.ijid.2016.12.004"},{"key":"109135","doi-asserted-by":"crossref","unstructured":"Gebeyehu E, Bantie L, Azage M. Inappropriate use of antibiotics and its associated factors among urban and rural communities of Bahir Dar City Administration, Northwest Ethiopia. PloS ONE. 2015;10:e0138179. https:\/\/doi.org\/10.1371\/journal.pone.0138179","DOI":"10.1371\/journal.pone.0138179"},{"key":"109136","doi-asserted-by":"crossref","unstructured":"Hicks LA, Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, Taylor TH Jr., et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60:1308-16. https:\/\/doi.org\/10.1093\/cid\/civ076","DOI":"10.1093\/cid\/civ076"},{"key":"109137","doi-asserted-by":"crossref","unstructured":"Hashimoto H, Matsui H, Sasabuchi Y, Yasunaga H, Kotani K, Nagai R, et al. Antibiotic prescription among outpatients in a prefecture of Japan, 2012-2013: A retrospective claims database study. BMJ Open. 2019;9:e026251. https:\/\/doi.org\/10.1136\/bmjopen-2018-026251","DOI":"10.1136\/bmjopen-2018-026251"},{"key":"109138","doi-asserted-by":"crossref","unstructured":"Machado-Alba JE, Valladales-Restrepo LF, Gaviria-Mendoza A, Machado-Duque ME, Figueras A. Patterns of antibiotic prescription in Colombia: Are there differences between capital cities and municipalities? Antibiotics. 2020;9. https:\/\/doi.org\/10.3390\/antibiotics9070389","DOI":"10.3390\/antibiotics9070389"},{"key":"109139","doi-asserted-by":"crossref","unstructured":"Dinos GP. The macrolide antibiotic renaissance. Br J Pharmacol. 2017;174:2967-83. https:\/\/doi.org\/10.1111\/bph.13936","DOI":"10.1111\/bph.13936"},{"key":"109140","unstructured":"World Health Organization (WHO). WHO Collaborating Centre for Drugs Statistics Methodology. Fecha de consulta: 30 de noviembre de 2020. Disponible en: http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"109141","unstructured":"Micromedex, Inc. Clarithromycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com"},{"key":"109142","unstructured":"Micromedex, Inc. Erythromycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com"},{"key":"109143","unstructured":"Micromedex, Inc. Azithromycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com"},{"key":"109144","unstructured":"Micromedex, Inc. Spiramycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com"},{"key":"109145","unstructured":"Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). Consulta de datos de productos. Fecha de consulta: 7 marzo de 2022. Disponible en: http:\/\/consultaregistro.invima.gov.co\/Consultas\/consultas\/consreg_encabcum.jsp"},{"key":"109146","doi-asserted-by":"crossref","unstructured":"Valderrama-Beltr\u00e1n S, Cort\u00e9s JA, Caro MA, Cely-Andrade L, Osorio-Pinz\u00f3n JV, Gualtero SM, et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y manejo de las infecciones de piel y tejidos blandos en Colombia. Infectio. 2019;23:318-46. https:\/\/doi.org\/10.22354\/in.v23i4.805","DOI":"10.22354\/in.v23i4.805"},{"key":"109147","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Huesca R, Lerma A, Guzm\u00e1n-Salda\u00f1a RME, Lerma C. Prevalence of antibiotics prescription and assessment of prescribed daily dose in outpatients from Mexico City. Antibiotics. 2020;9:38. https:\/\/doi.org\/10.3390\/antibiotics9010038","DOI":"10.3390\/antibiotics9010038"},{"key":"109148","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Choez X, Armijos-Acurio ML, Jimbo-Sotomayor RE. Appropriateness and adequacy of antibiotic prescription for upper respiratory tract infections in ambulatory health care centers in Ecuador. BMC Pharmacol Toxicol. 2018;19:46. https:\/\/doi.org\/10.1186\/s40360-018-0237-y","DOI":"10.1186\/s40360-018-0237-y"},{"key":"109149","doi-asserted-by":"crossref","unstructured":"Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Yusof FA, Kamal M, et al. Prescribing patterns for upper respiratory tract infections: A prescription-review of primary care practice in Kedah, Malaysia, and the implications. Expert Rev Anti Infect Ther. 2015;13:1547-56. https:\/\/doi.org\/10.1586\/14787210.2015.1085303","DOI":"10.1586\/14787210.2015.1085303"},{"key":"109150","doi-asserted-by":"crossref","unstructured":"Aljadeeah S, Wirtz VJ, Nagel E. Outpatient antibiotic dispensing for the population with government health insurance in Syria in 2018-2019. Antibiotics. 2020;9. https:\/\/doi.org\/10.3390\/antibiotics9090570","DOI":"10.3390\/antibiotics9090570"},{"key":"109151","doi-asserted-by":"crossref","unstructured":"Islam MA, Akhtar Z, Hassan MZ, Chowdhury S, Rashid MM, Aleem MA, et al. Pattern of antibiotic dispensing at pharmacies according to the WHO Access, Watch, Reserve (AWaRe) classification in Bangladesh. Antibiotics (Basel). 2022;11:247. https:\/\/doi.org\/10.3390\/antibiotics11020247","DOI":"10.3390\/antibiotics11020247"},{"key":"109152","doi-asserted-by":"crossref","unstructured":"King LM, Lovegrove MC, Shehab N, Tsay S, Budnitz DS, Geller AI, et al. Trends in US outpatient antibiotic prescriptions during the Coronavirus Disease 2019 pandemic. Clin Infect Dis. 2021;73:e652-60. https:\/\/doi.org\/10.1093\/cid\/ciaa1896","DOI":"10.1093\/cid\/ciaa1896"},{"key":"109153","doi-asserted-by":"crossref","unstructured":"Adriaenssens N, Bruyndonckx R, Versporten A, Hens N, Monnet DL, Molenberghs G, et al. Consumption of macrolides, lincosamides and streptogramins in the community, European Union\/European Economic Area, 1997-2017. J Antimicrob Chemother. 2021;76(Suppl.2):ii2-ii6. https:\/\/doi.org\/10.1093\/jac\/dkab175","DOI":"10.1093\/jac\/dkab175"},{"key":"109154","doi-asserted-by":"crossref","unstructured":"Al-Azzam S, Mhaidat NM, Banat HA, Alfaour M, Ahmad DS, Muller A, et al. An assessment of the impact of Coronavirus Disease (COVID-19) pandemic on national antimicrobial consumption in Jordan. Antibiotics (Basel). 2021;10:690. https:\/\/doi.org\/10.3390\/antibiotics10060690","DOI":"10.3390\/antibiotics10060690"},{"key":"109155","doi-asserted-by":"crossref","unstructured":"Hussain AZ, Paudyal V, Hadi MA. Impact of the COVID-19 pandemic on the prescribing patterns of first-line antibiotics in English primary care: A longitudinal analysis of national prescribing dataset. Antibiotics (Basel). 2021;10:591. https:\/\/doi.org\/10.3390\/antibiotics10050591","DOI":"10.3390\/antibiotics10050591"},{"key":"109156","doi-asserted-by":"crossref","unstructured":"Buehrle DJ, Wagener MM, Nguyen MH, Clancy CJ. Trends in outpatient antibiotic prescriptions in the United States during the COVID-19 pandemic in 2020. JAMA Network Open. 2021;4:e2126114-e. https:\/\/doi:10.1001\/jamanetworkopen.2021.26114","DOI":"10.1001\/jamanetworkopen.2021.26114"},{"key":"109157","unstructured":"Ministerio de Salud y Protecci\u00f3n Social, Colombia. Resoluci\u00f3n 3512 de 2019, Actualizaci\u00f3n Plan de Beneficios. Fecha de consulta: 7 de marzo de 2022. Disponible en: https:\/\/www.minsalud.gov.co\/salud\/POS\/Paginas\/plan-obligatorio-de-salud-pos.aspx"},{"key":"109158","doi-asserted-by":"crossref","unstructured":"Doorakkers E, Lagergren J, Gajulapuri VK, Callens S, Engstrand L, Brusselaers N. Helicobacter pylori eradication in the Swedish population. Scand J Gastroenterol. 2017;52:678-85. https:\/\/doi.org\/10.1080\/00365521.2017.1303844","DOI":"10.1080\/00365521.2017.1303844"},{"key":"109159","doi-asserted-by":"crossref","unstructured":"Cohen SS, Alexander DD, Krebs NF, Young BE, Cabana MD, Erdmann P, et al. Factors associated with breastfeeding initiation and continuation: A meta-analysis. J Pediatr. 2018;203:190-6.e21. https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.008","DOI":"10.1016\/j.jpeds.2018.08.008"},{"key":"109160","unstructured":"G\u00f3mez M, Otero W, Guti\u00e9rrez \u00d3. Tratamiento de la infecci\u00f3n por Helicobacter pylori. Encuesta en un grupo de m\u00e9dicos generales y especialistas en Colombia. Rev Colomb Gastroenterol. 2007;22:7-16."},{"key":"109161","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report. Gut. 2017;66:6-30. https:\/\/doi.org\/10.1136\/gutjnl-2016-312288","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"109162","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Garc\u00eda M, M\u00e1iz L, Olveira C, Gir\u00f3n RM, de la Rosa D, Blanco M, et al. Spanish Guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol (Engl Ed). 2018;54:88-98. https:\/\/doi.org\/10.1016\/j.arbres.2017.07.016","DOI":"10.1016\/j.arbr.2017.07.014"},{"key":"109163","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez GV, Shapiro DJ, Hersh AL, Hicks LA, Fleming-Dutra KE. Outpatient macrolide antibiotic prescribing in the United States, 2008-2011. Open Forum Infect Dis. 2017;4:ofx220-ofx. https:\/\/doi.org\/10.1093\/ofid\/ofx220","DOI":"10.1093\/ofid\/ofx220"},{"key":"109164","doi-asserted-by":"crossref","unstructured":"Montufar F, \u00c1lvarez C, Giraldo-Cadavid L, Aguirre C, Var\u00f3n F, Ali Munive A. Recomendaciones para el diagn\u00f3stico, tratamiento y prevenci\u00f3n de la neumon\u00eda adquirida en la comunidad en adultos inmunocompetentes. Infectio. 2013;17:1-38. https:\/\/doi.org\/10.1016\/S0123-9392(13)70019-5","DOI":"10.1016\/S0123-9392(13)70019-5"},{"key":"109165","doi-asserted-by":"crossref","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45-e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"109166","doi-asserted-by":"crossref","unstructured":"Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community-acquired pneumonia in children: Update 2011. Thorax. 2011;66(Suppl.2):ii1-23. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200598","DOI":"10.1136\/thoraxjnl-2011-200598"},{"key":"109167","doi-asserted-by":"crossref","unstructured":"Shively NR, Buehrle DJ, Clancy CJ, Decker BK. Prevalence of inappropriate antibiotic prescribing in primary care clinics within a veterans affairs health care system. Antimicrob Agents Chemother. 2018;62:e00337-18. https:\/\/doi.org\/10.1128\/AAC.00337-18","DOI":"10.1128\/AAC.00337-18"},{"key":"109168","doi-asserted-by":"crossref","unstructured":"Saleem Z, Saeed H, Hassali MA, Godman B, Asif U, Yousaf M, et al. Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: A longitudinal surveillance and implications. Antimicrob Resist Infect Control. 2019;8:188. https:\/\/doi.org\/10.1186\/s13756-019-0649-5","DOI":"10.1186\/s13756-019-0649-5"},{"key":"109169","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n-Parra J, Mui\u00f1o-Miguez A, Bendala-Estrada AD, Ramos-Mart\u00ednez A, Mu\u00f1ez-Rubio E, Fern\u00e1ndez-Carracedo E, et al. Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PloS ONE. 2021;16:e0251340.","DOI":"10.1371\/journal.pone.0251340"},{"key":"109170","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1371\/journal.pone.0251340","DOI":"10.1371\/journal.pone.0251340"},{"key":"109171","doi-asserted-by":"crossref","unstructured":"Bianco A, Papadopoli R, Mascaro V, Pileggi C, Pavia M. Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners. J Glob Antimicrob Resist. 2018;11:2199-205. https:\/\/doi.org\/10.2147\/IDR.S170349","DOI":"10.2147\/IDR.S170349"},{"key":"109172","doi-asserted-by":"crossref","unstructured":"Machado-Duque M, Mercado-G\u00f3mez K, Bernal-Chica M, Uribe-V\u00e9lez S, Machado-Alba J. Prescripci\u00f3n e indicaciones de uso de fluoroquinolonas en un grupo de pacientes ambulatorios de Colombia. Biom\u00e9dica. 2020;40:382-90. https:\/\/doi.org\/10.7705\/biomedica.5103","DOI":"10.7705\/biomedica.5103"},{"key":"109173","doi-asserted-by":"crossref","unstructured":"Valladales-Restrepo LF, Constain-Mosquera CA, \u00c1lvarez-Amaya V, Machado-Alba JE. Study of prescription-indication of tetracyclines in a population in Colombia. Fundam Clin Pharmacol. 2021;36:390-6. https:\/\/doi.org\/10.1111\/fcp.12724","DOI":"10.1111\/fcp.12724"},{"key":"109174","doi-asserted-by":"crossref","unstructured":"Nowakowska M, van Staa T, M\u00f6lter A, Ashcroft DM, Tsang JY, White A, et al. Antibiotic choice in UK general practice: Rates and drivers of potentially inappropriate antibiotic prescribing. J. Antimicrob. Chemother. 2019;74:3371-8. https:\/\/doi.org\/10.1093\/jac\/dkz345","DOI":"10.1093\/jac\/dkz345"},{"key":"109175","unstructured":"Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults. Am Fam Physician. 2012;86:153-9."},{"key":"109176","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56:105949. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"109177","doi-asserted-by":"crossref","unstructured":"Verdejo C, Vergara-Merino L, Meza N, P\u00e9rez-Bracchiglione J, Carvajal-Juli\u00e1 N, Madrid E, et al. Macrolides for the treatment of COVID-19: A living, systematic review. Medwave. 2020;20:e8074. https:\/\/doi.org\/10.5867\/medwave.2020.11.8073","DOI":"10.31219\/osf.io\/rvp59"},{"key":"109178","doi-asserted-by":"crossref","unstructured":"Estrada-Orozco K, Saavedra C. Manejo del paciente con infecci\u00f3n por SARS-CoV-2\/COVID-19. Infectio. 2021;25(Supl.1):78-123. https:\/\/doi.org\/10.22354\/in.v25i4.975","DOI":"10.22354\/in.v25i4.975"},{"key":"109179","doi-asserted-by":"crossref","unstructured":"Bonaldo G, Andriani LA, D\u2019Annibali O, Motola D, Vaccheri A. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2019;28:1457-63. https:\/\/doi.org\/10.1002\/pds.4873","DOI":"10.1002\/pds.4873"},{"key":"109180","doi-asserted-by":"crossref","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V. Development of a risk score for QTc-prolongation: The RISQ-PATH study. Int J Clin Pharm. 2017;39:424-32. https:\/\/doi.org\/10.1007\/s11096-017-0446-2","DOI":"10.1007\/s11096-017-0446-2"},{"key":"109181","unstructured":"Global Strategy for Asthma Management and Prevention. 2021 GINA Report, Global Strategy for Asthma Management and Prevention. Fecha de consulta: 9 de enero de 2021. Disponible en: https:\/\/ginasthma.org\/"},{"key":"109182","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; 2021. Fecha de consulta: 9 de enero de 2021. Disponible en: https:\/\/ginasthma.org\/gina-reports\/"},{"key":"109183","doi-asserted-by":"crossref","unstructured":"Siqueira JF, R\u00f4\u00e7as IN. Microbiology and treatment of acute apical abscesses. Clin Microbiol Rev. 2013;26:255-73. https:\/\/doi.org\/10.1128\/CMR.00082-12","DOI":"10.1128\/CMR.00082-12"},{"key":"109184","unstructured":"Shweta, Prakash SK. Dental abscess: A microbiological review. Dent Res J (Isfahan). 2013;10:585-91."},{"key":"109185","doi-asserted-by":"crossref","unstructured":"Jevon P, Abdelrahman A, Pigadas N. Management of odontogenic infections and sepsis: An update. Br Dent J. 2020;229:363-70. https:\/\/doi.org\/10.1038\/s41415-020-2114-5","DOI":"10.1038\/s41415-020-2114-5"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6116\/5043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6116\/5043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T20:19:58Z","timestamp":1660249198000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/6116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.6116","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"2022-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Presentaci\u00f3n de caso","name":"content_type","label":"Content Type"}]}}